丽珠集团最新公告：公司产品纳入医保目录

Core Points - The company, Lizhu Group, announced that it has a total of 194 products included in the National Medical Insurance Directory for 2025, comprising 92 Class A and 102 Class B products [1] - The injectable Aripiprazole microspheres have been included in the National Medical Insurance Directory for the first time through negotiations, while the injectable Triptorelin acetate microspheres have a new indication added, and the injectable Esomeprazole sodium has successfully renewed its contract [1]